Dianthus Therapeutics, Inc. (DNTH)
110.08
-1.02
(-0.92%)
USD |
NASDAQ |
Aug 24, 16:00
110.08
0.00 (0.00%)
After-Hours: 20:00
Dianthus Therapeutics Total Liabilities (Quarterly) : 41.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.25M |
| March 31, 2026 | 45.57M |
| December 31, 2025 | 38.00M |
| September 30, 2025 | 30.99M |
| June 30, 2025 | 23.00M |
| March 31, 2025 | 19.97M |
| December 31, 2024 | 21.76M |
| September 30, 2024 | 16.35M |
| June 30, 2024 | 10.74M |
| March 31, 2024 | 9.775M |
| December 31, 2023 | 10.54M |
| September 30, 2023 | 14.08M |
| June 30, 2023 | 4.034M |
| March 31, 2023 | 5.982M |
| December 31, 2022 | 9.454M |
| September 30, 2022 | 40.10M |
| June 30, 2022 | 39.44M |
| March 31, 2022 | 43.20M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.26M |
| September 30, 2021 | 16.55M |
| June 30, 2021 | 17.49M |
| March 31, 2021 | 15.56M |
| December 31, 2020 | 17.71M |
| September 30, 2020 | 16.08M |
| June 30, 2020 | 16.81M |
| March 31, 2020 | 19.04M |
| December 31, 2019 | 20.32M |
| September 30, 2019 | 15.70M |
| June 30, 2019 | 15.88M |
| March 31, 2019 | 13.69M |
| December 31, 2018 | 11.66M |
| September 30, 2018 | 13.01M |
| June 30, 2018 | 8.401M |
| March 31, 2018 | 5.493M |
| December 31, 2017 | 4.142M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Legend Biotech Corp. | 521.32M |
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Verastem, Inc. | 156.52M |
| Fortress Biotech, Inc. | 110.63M |
| AbbVie, Inc. | 141.00B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.213B |
| Shareholders Equity (Quarterly) | 1.172B |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 26.10 |
| Net Debt Paydown Yield | 0.00% |